About
Company
Latest News
Contact Us
History
Careers
Policies
Editorial Policies
Open Access Policy
Research and Publication Ethics
Peer-review Policies
Publication Fees
Advertising Policy
Journals
All Journals
Active Journals
Archived Journals
Services
Language Editing
Layout & Production
Graphic Abstracts
Video Abstracts
Submission System
Collaborations
Strategic Collaborators
Journal Membership
Conference Parterships
Insights
Latest Articles
Academic Talks
Interactive Webinars
Academic Support
Author Hub
Editor Hub
Reviewer Hub
Conference Organizer
Expert Lecture
Search
Log In
Home
Volumes
Volume1
Volume1, Issue1 (2018)
Volume
Cancer drug resistance: a new perspective
How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?
Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomas
Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations
Reduction of mitomycin C resistance in human bladder cancer T24 cells by knocking-down ras oncogene
Resistance mechanism to cisplatin in NCI-H460 non-small cell lung cancer cell line: investigating apoptosis, autophagy, and cytogenetic damage
Actions for 0 selected articles
Download PDFs >
Cancer Drug Resistance
ISSN 2578-532X (Online)
editorial@cdrjournal.com
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/